Dietary supplementation with vitamins C and E prevents downregulation of endothelial NOS expression in hypercholesterolemia in vivo and in vitro

Atherosclerosis

Volumn 165, Issue 1, 2002, Pages 33-40

  Rodríguez, José A ^a   Grau, Andrés ^a   Eguinoa, Ezequiel ^a   Nespereira, Beatriz ^a   Pérez Ilzarbe, Maitane ^a   Arias, Roberto ^a   Belzunce, Maria S ^a   Páramo, José A ^a   Martínez Caro, Diego ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Atherosclerosis; Endothelium; Lipoproteins; Nitric oxide; Swine; Tocopherol

Indexed keywords

ACETYLCHOLINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CHOLESTEROL DIET; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HYPERCHOLESTEROLEMIA; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; VASOMOTOR REFLEX;

ANALYSIS OF VARIANCE; ANIMALS; ASCORBIC ACID; BLOTTING, WESTERN; CELLS, CULTURED; CORONARY VESSELS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; MALE; NITRIC OXIDE SYNTHASE; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SWINE; VITAMIN E;

EID: 0036839916     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00188-0     Document Type: Article

References (30)

1. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
2. Wever R.M., Luscher T.F., Cosentino F., Rabelink T.J. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation. 97:1998;108-112.
3. Mathew V., Cannan C.R., Miller V.M., et al. Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia. Circulation. 96:1997;1930-1936.
4. Lusis A.J. Atherosclerosis. Nature. 407:2000;233-241.
5. Orbe J., Rodríguez J., Calvo A., et al. Antioxidants attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty. Cardiovasc. Res. 48:2001;484-492.
6. Liao J.K., Shin W.S., Lee W.Y., Clark S.L. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270:1995;319-324.
7. Feron O., Dessy C., Moniotte S., Desager J.P., Balligand J.L. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J. Clin. Invest. 20:1999;897-905.
8. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100:1997;2153-2157.
9. Carr A.C., Zhu B.Z., Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ. Res. 87:2000;349-354.
10. Gilligan D.M., Sack M.N., Guetta V., et al. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J. Am. Coll. Cardiol. 24:1994;1611-1617.
11. Keaney J.F. Jr., Guo Y., Cunningham D., Shwaery G.T., Xu A., Vita J.A. Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J. Clin. Invest. 98:1996;386-394.
12. Kinlay S., Fang J.C., Hikita H., et al. Plasma alpha-tocopherol and coronary endothelium-dependent vasodilator function. Circulation. 100:1999;219-221.
13. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
14. Talwar D., Ha T.K.K., Cooney J., Brownlee C., O'Reilly D.S.J. A routine method for the simultaneous measurement of retinol, alpha-tocopherol and five carotenoids in human plasma by reverse phase HPLC. Clin. Chim. A. 270:1998;85-100.
15. Chapman M.J., Goldstein S., Lagrange D., Laplaud P.M. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J. Lipid Res. 22:1981;339-358.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement by the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
17. Allain C.C., Poon L.S., Chan C.S., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 20:1974;470-475.
18. Saadi S., Holzknecht R.A., Patte C.P., Stern D.M., Platt J.L. Complement-mediated regulation of tissue factor activity in endothelium. J. Exp. Med. 182:1995;1807-1814.
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
20. García-Bolao I., Merino J., Martínez A., Grau A., Alegría E., Martinez Caro D. Effect of hypercholesterolaemia on platelet growth factors. Eur. J. Clin. Invest. 26:1996;929-935.
21. Nunes G.L., Sgoutas D.S., Redden R.A., Sigman S.R., Gravanis M.B., King S.B. Jr. Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler. Thromb. Vasc. Biol. 15:1995;156-165.
22. Brandes R.P., Schmitz Winnenthal F.H., Feletou M., et al. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc. Natl. Acad. Sci. USA. 97:2000;9747-9752.
23. Hernandez Perera O., Perez Sala D., Navarro Antolin J., et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J. Clin. Invest. 101:1998;2711-2719.
24. Vidal F., Colome C., Martinez Gonzalez J., Badimon L. Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells. Eur. J. Biochem. 252:1998;378-384.
25. Boger R.H., Bode Boger S.M., Phivthong ngam L., et al. Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis. 141:1998;31-43.
26. Meydani M. Vitamin E and atherosclerosis: beyond prevention of LDL oxidation. J. Nutr. 131:2001;366S-368S.
27. Upston J.M., Terentis A.C., Stocker R. Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J. 13:1999;977-994.
28. Azzi A., Breyer I., Feher M., Ricciarelli R., Stocker A., Zimmer S. Nonantioxidant functions of alpha-tocopherol in smooth muscle cells. J. Nutr. 131:2001;378S-381S.
29. Herrmann J., Lerman L.O., Rodriguez Porcel M., Holmes D.R. Jr., Richardson D.M. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc. Res. 51:2001;762-766.
30. Violi F., Micheletta F., Iuliano L. Vitamin E, atherosclerosis and thrombosis. Thromb. Haemost. 85:2001;766-770.